Rockport Venture Partners - Benefits To Companies

Through Rockport, companies gain access to institutional investors that are focused on the
life science sector and that can provide resources complementary to those of an existing shareholder base.

European and Asian institutional funds, as in the U.S., are managed by individuals with local operating expertise, corporate contacts and scientific backgrounds. Through relationships with such individuals, companies can gain valuable access to clinical leaders, local market players, distribution partners and corporate leaders worldwide. For U.S. companies that are conducting clinical trials in Europe, planning for an OUS product launch, or seeking global partnering opportunities, the strategic value of having international investors includes access to European and Asian clinical leaders, local market and regulatory knowledge, and introductions to distribution partners and corporate leaders worldwide.

For public companies seeking to complete a PIPE, or for private companies contemplating a future IPO, the strategic value of crossover or hedge fund shareholders includes global visibility for public equity buy-side relationships, transactional expertise in and understanding of the public market environment, and credibility among institutions that could become large, stabilizing shareholders. With longer term investment horizons and experience in developing life science companies, venture funds in Rockport’s network also can provide a highly attractive financing resource for public companies.

Benefits to companies include:

Diversified Shareholder Base – Rockport’s global network of investors can provide companies with benefits and resources to complement those provided by an existing shareholder base. As an example, for successful companies with multiple top-tier U.S. based venture firms as shareholders, the 8th, 9th, or 10th domestic venture firm provides potentially duplicative resources and impact. On the other hand, European, Asian and crossover institutional investors can provide differentiated and valuable strategic resources to aid the growth of the company.

Global Strategic Resources – Rockport’s international network of private equity funds are managed by professionals with life science industry operating and financial experience within their geographic region. For a U.S. company that is either conducting clinical trials, seeking global M&A opportunities, or considering a product launch in Europe or Asia due to lower regulatory hurdles, European and Asian investors can provide strategic value in many
ways including direct introductions to European and/or Asian clinical thought leaders, access
to international corporate decision makers for in-licensing, out-licensing, or
distribution opportunities.

Recognition and Credibility In The Public Equity Markets – The globally recognized public equity, cross over and hedge funds in Rockport’s network can improve a company’s visibility in the public equity markets. Companies can benefit from introductions to prospective analysts that may initiate research coverage and influence relationships with institutions that could become large, stabilizing shareholders.

Lead Investor and Deal Oversubscription – With a proven track record of representing high quality investment opportunities, Rockport is recognized throughout Europe and Asia as the leading private placement firm in the life science sector. As a result, Rockport has brought the lead or co-lead investor to over 70% of the transactions it has represented, and in 50% of its transactions Rockport has raised more than 2X its targeted allocation.*

Efficient Process – The Principals of Rockport have developed an efficient financing process based on their collective experience in successfully completing over 45 financing transactions during their careers. Rockport recognizes the time, burden and distraction that a financing can demand of a management team and will seek to minimize that by appropriately selecting its investor audience.

Non-exclusive, Success Fee Based Engagements – Rockport partners with companies on a non-exclusive and success fee only basis. Company management is free to contact their own capital resources. Rockport is only compensated on commitments from its pre-agreed
network of investors.